Pharmaceutical giant Johnson & Johnson is currently under fire as the subject of thousands of lawsuits involving defective products, including both their metal-on-metal hip implant systems and vaginal mesh. But it seems that is not their only problem. The Maharashtra
Congress Asks SEC to Enforce Consumer Protections
May 02, 2013
by Amy Sayre, Paralegal
Congress does not have the reputation lately of working for the people. Stalemates between Republicans and Democrats continue to halt progress in both bodies of Congress. However, amidst their inability to seemingly get anything done, 37 members of the Senate
Trio of New Class Certification Decisions in the Seventh Circuit
February 19, 2013
by Thomas Doyle, Of Counsel
In the last few months, the U.S. Court of Appeals for the Seventh Circuit has issued three opinions on the topic of how trial courts should decide motions for class certification when some questions will require individualized proof. Judge Richard
Pro-Consumer Initiatives: Lobbying and Litigation
February 12, 2013
by Amber Nesbitt, Associate
In the weeks leading up to his State of the Union address tonight, President Obama was surely inundated with reports, requests, and letters from various advocacy groups urging him to not only adopt their platform, but to make it a
Legal Pads and Spit Up Rags: A New Mom on Making it Work
February 08, 2013
by Dawn Goulet, Associate
Balancing and juggling. A working mom’s life often sounds like a circus performance. The words carry with them an insidious threat. Let your guard down for a moment and the whole thing may fall apart. I’ve been back in the
Hall of Shame: Chinese Chicken Jerky Dog Treats and the FDA
January 31, 2013
by Amy Sayre, Paralegal
For years, the U.S. Food and Drug Administration (“FDA”) has been investigating a possible contamination in chicken jerky dog treats. The investigation began in 2007 (on the heels of the massive recall of melamine-tainted pet food in the U.S. and
Innovator Liability Opens Doors to Recovery for Generic Drug Consumers
January 28, 2013
by Corey Raines, Associate
After the U.S. Supreme Court decided PLIVA, Inc. v. Mensing in 2011, generic drug users were left searching for possible avenues of legal recovery after incurring injury. The Mensing decision, which held that state law failure-to-warn claims cannot be brought
